Literature DB >> 20420848

Exposure to chronic intermittent nicotine vapor induces nicotine dependence.

Olivier George1, Taryn E Grieder, Maury Cole, George F Koob.   

Abstract

Animal models of drug exposure are important tools for the study of the neurobiological mechanisms of nicotine dependence and as preclinical models for medication development. There are few non-invasive animal models of nicotine exposure and currently there is no known animal model of second-hand exposure to nicotine. We hypothesized that chronic administration of nicotine vapors would produce blood levels of nicotine in rodents that are clinically relevant to those observed in human smoking and that rodents exposed to nicotine vapors would develop dependence to nicotine. We developed a system that vaporizes nicotine in the air in a stable, reliable and consistent manner. Intermittent exposure to nicotine vapor (0.2mg/m(3)) for 8 or 14h per day for 7days produced a concentration of nicotine in the blood of 22ng/mL. Sixteen hours after removal from nicotine vapors, rats showed significant somatic withdrawal signs precipitated by mecamylamine (1.5mg/kg). These results provide a new rodent model of nicotine dependence using vapor administration that produces consistent levels of nicotine in the blood that are relevant for both heavy smoking and second-hand smoking, using a non-invasive technique that mimics the intermittent aspect and route of administration in humans. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420848      PMCID: PMC2878929          DOI: 10.1016/j.pbb.2010.04.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy.

Authors:  B W Seymour; K E Pinkerton; K E Friebertshauser; R L Coffman; L J Gershwin
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 2.  Inhalation studies with drugs of abuse.

Authors:  Y Meng; A H Lichtman; D T Bridgen; B R Martin
Journal:  NIDA Res Monogr       Date:  1997

3.  Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.

Authors:  S S Watkins; L Stinus; G F Koob; A Markou
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

Review 4.  Tobacco and health: a societal challenge.

Authors:  E L Wynder; D Hoffmann
Journal:  N Engl J Med       Date:  1979-04-19       Impact factor: 91.245

Review 5.  Assessment of exposure to environmental tobacco smoke.

Authors:  M S Jaakkola; J J Jaakkola
Journal:  Eur Respir J       Date:  1997-10       Impact factor: 16.671

6.  Rodent model of nicotine abstinence syndrome.

Authors:  D H Malin; J R Lake; P Newlin-Maultsby; L K Roberts; J G Lanier; V A Carter; J S Cunningham; O B Wilson
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

Review 7.  Smoking and reproductive health.

Authors:  E Weisberg
Journal:  Clin Reprod Fertil       Date:  1985-09

8.  Long-term effects of inhaled nicotine.

Authors:  H L Waldum; O G Nilsen; T Nilsen; H Rørvik; V Syversen; A K Sanvik; O A Haugen; S H Torp; E Brenna
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

9.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; K M Hebert; D L Conrad; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

10.  Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine.

Authors:  Taryn E Grieder; Laurie H Sellings; Hector Vargas-Perez; Ryan Ting-A-Kee; Eric C Siu; Rachel F Tyndale; Derek van der Kooy
Journal:  Neuropsychopharmacology       Date:  2009-12-23       Impact factor: 7.853

View more
  23 in total

1.  Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal.

Authors:  Taryn E Grieder; Olivier George; Huibing Tan; Susan R George; Bernard Le Foll; Steven R Laviolette; Derek van der Kooy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

2.  Nicotine e-cigarette vapor inhalation effects on nicotine & cotinine plasma levels and somatic withdrawal signs in adult male Wistar rats.

Authors:  Christian Montanari; Leslie K Kelley; Tony M Kerr; Maury Cole; Nicholas W Gilpin
Journal:  Psychopharmacology (Berl)       Date:  2019-11-23       Impact factor: 4.530

3.  Delivery of nicotine aerosol to mice via a modified electronic cigarette device.

Authors:  Timothy W Lefever; Youn O K Lee; Alexander L Kovach; Melanie A R Silinski; Julie A Marusich; Brian F Thomas; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2017-01-18       Impact factor: 4.492

4.  A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers.

Authors:  Xuesi M Shao; Briana Lopez; David Nathan; Julian Wilson; Emmanuel Bankole; Hayk Tumoyan; Alexandra Munoz; Jorge Espinoza-Derout; Kamrul M Hasan; Scarlett Chang; Christina Du; Amiya P Sinha-Hikim; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Neurosci Methods       Date:  2019-07-27       Impact factor: 2.390

5.  Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.

Authors:  Jacques D Nguyen; Shawn M Aarde; Maury Cole; Sophia A Vandewater; Yanabel Grant; Michael A Taffe
Journal:  Neuropsychopharmacology       Date:  2016-06-09       Impact factor: 7.853

6.  Exposure to passive nicotine vapor in male adolescent rats produces a withdrawal-like state and facilitates nicotine self-administration during adulthood.

Authors:  Marsida Kallupi; Giordano de Guglielmo; Estefania Larrosa; Olivier George
Journal:  Eur Neuropsychopharmacol       Date:  2019-08-26       Impact factor: 4.600

7.  Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.

Authors:  Xuesi M Shao; Siyu Liu; Eon S Lee; David Fung; Hua Pei; Jing Liang; Ross Mudgway; Jingxi Zhang; Jack L Feldman; Yifang Zhu; Stan Louie; Xinmin S Xie
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

8.  A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps.

Authors:  Julia K Brynildsen; Julie Najar; Li-Ming Hsu; D Bruce Vaupel; Hanbing Lu; Thomas J Ross; Yihong Yang; Elliot A Stein
Journal:  Pharmacol Biochem Behav       Date:  2016-01-02       Impact factor: 3.533

9.  Nicotine vapor inhalation escalates nicotine self-administration.

Authors:  Nicholas W Gilpin; Annie M Whitaker; Brittni Baynes; Abdelrahim Y Abdel; Madelyn T Weil; Olivier George
Journal:  Addict Biol       Date:  2012-12-14       Impact factor: 4.280

Review 10.  Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

Authors:  Lauren C Smith; Olivier George
Journal:  Neuropharmacology       Date:  2020-08-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.